1st Quarter - Report — SEQIRUS for SEQIRUS (2023)

Firm

SEQIRUS

Client

SEQIRUS

Income

—

Expenses

$210,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY2024 Appropriations, FY2024 President's Budget proposals, supplemental appropriations, H.R. 9476 Protecting America from Seasonal and Pandemic Influenza Act of 2022, Pandemic and All-Hazards Preparedness Reauthorization, Department of Defense and Veterans Administration acquisition of influenza vaccine

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

Lobbyist	Covered position, as disclosed
CHRISTINE FARQUHARSON	—

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Natl Security Council (NSC)

Bills named: H.R. 9476 (118th)

Health Issues HCR

Issues related to pandemic preparedness and seasonal and pandemic influenza preparedness.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.

Lobbyist	Covered position, as disclosed
CHRISTINE FARQUHARSON	—

Contacted: Defense, Dept of (DOD); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.